Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 3, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	32,062	39,886	31,280	39,725	64,755	11,785
Market Cap Growth	-5.81%	27.51%	-21.26%	-38.65%	449.47%	-21.97%
Enterprise Value	37,672	45,531	36,863	44,228	67,914	15,991
Last Close Price	348.50	433.27	336.30	426.18	688.25	124.01
PE Ratio	21.01	23.27	18.81	19.38	23.09	8.34
PS Ratio	1.82	1.58	1.15	1.60	3.01	0.65
PB Ratio	3.31	3.11	2.62	3.83	7.09	1.81
P/TBV Ratio	3.32	3.20	2.68	3.83	7.09	1.81
P/FCF Ratio	30.08	-	-	97.06	5.81
P/OCF Ratio	11.11	23.46	56.42	41.79	4.70
EV/Sales Ratio	1.62	1.80	1.36	1.78	3.15	0.89
EV/EBITDA Ratio	13.05	14.50	12.17	13.19	15.67	6.23
EV/EBIT Ratio	15.92	17.18	14.44	15.34	17.50	7.49
EV/FCF Ratio	34.34	-	-	101.79	7.89
Debt / Equity Ratio	0.46	0.44	0.51	0.52	0.38	0.60
Debt / EBITDA Ratio	2.04	1.79	1.99	1.60	0.80	1.49
Debt / FCF Ratio	-	4.26	-	-	5.26	1.92
Asset Turnover	-	1.04	1.17	1.25	1.29	1.19
Inventory Turnover	-	3.39	3.67	3.62	3.60	4.15
Quick Ratio	-	0.92	0.94	0.84	0.97	0.82
Current Ratio	-	1.66	1.57	1.48	1.78	1.45
Return on Equity (ROE)	-	13.87%	14.93%	21.03%	35.81%	23.65%
Return on Assets (ROA)	-	6.83%	6.89%	9.07%	14.52%	8.80%
Return on Capital (ROIC)	8.06%	9.08%	9.44%	12.68%	21.04%	12.75%
Return on Capital Employed (ROCE)	-	16.20%	17.30%	22.70%	33.20%	22.40%
Earnings Yield	4.76%	4.30%	5.32%	5.16%	4.33%	12.00%
FCF Yield	3.32%	-1.01%	-2.05%	1.03%	17.20%
Dividend Yield	0.29%	0.23%	0.30%	0.24%	0.36%	0.40%
Payout Ratio	0.00%	5.41%	5.65%	4.64%	8.28%	4.97%
Buyback Yield / Dilution	0.87%	0.72%	-	0.64%	-	1.20%
Total Shareholder Return	1.16%	0.95%	0.30%	0.88%	0.36%	1.60%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.